Insider Transactions in Q4 2021 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2021
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
28,290
-50.24%
|
$1,273,050
$45.79 P/Share
|
|
Dec 27
2021
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,290
+32.61%
|
$565,800
$20.45 P/Share
|
|
Dec 27
2021
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
4,166
-38.11%
|
$183,304
$44.37 P/Share
|
|
Dec 27
2021
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+27.59%
|
$20,830
$5.46 P/Share
|
|
Dec 23
2021
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
15,000
-68.92%
|
$675,000
$45.0 P/Share
|
|
Dec 23
2021
|
Edward M. Md Kaye Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+40.8%
|
$105,000
$7.61 P/Share
|
|
Dec 09
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
29,166
-8.67%
|
$1,049,976
$36.49 P/Share
|
|
Dec 09
2021
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
29,166
+7.82%
|
$174,996
$6.3 P/Share
|
|
Nov 19
2021
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
29,032
-51.52%
|
$1,190,312
$41.21 P/Share
|
|
Nov 19
2021
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,032
+33.26%
|
$348,384
$12.03 P/Share
|
|
Nov 12
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
4,143
-1.14%
|
$161,577
$39.63 P/Share
|
|
Nov 12
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,143
+1.12%
|
$24,858
$6.0 P/Share
|
|
Nov 11
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.33%
|
$78,000
$39.56 P/Share
|
|
Nov 09
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
45,000
-13.94%
|
$1,845,000
$41.76 P/Share
|
|
Nov 09
2021
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+12.23%
|
$405,000
$9.65 P/Share
|
|
Nov 08
2021
|
L Patrick Gage Director |
SELL
Open market or private sale
|
Direct |
26,468
-28.06%
|
$1,085,188
$41.33 P/Share
|
|
Nov 08
2021
|
L Patrick Gage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,468
+20.75%
|
$105,872
$4.74 P/Share
|
|
Nov 05
2021
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
30,996
-51.49%
|
$1,239,840
$40.0 P/Share
|
|
Nov 05
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,996
+33.24%
|
$309,960
$10.07 P/Share
|
|
Nov 05
2021
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
8,503
-39.08%
|
$340,120
$40.0 P/Share
|
|
Nov 05
2021
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,503
+28.1%
|
$42,515
$5.88 P/Share
|
|
Nov 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.13%
|
$850,000
$34.89 P/Share
|
|
Nov 01
2021
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.42%
|
$150,000
$6.0 P/Share
|
|
Oct 29
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$175,000
$35.8 P/Share
|
|
Oct 29
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.35%
|
$30,000
$6.0 P/Share
|
|
Oct 19
2021
|
Ching Jaw SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
35,687
-40.21%
|
$1,249,045
$35.73 P/Share
|
|
Oct 19
2021
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
10,332
-45.53%
|
$361,620
$35.73 P/Share
|
|
Oct 19
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,332
+30.34%
|
$61,992
$6.72 P/Share
|
|
Oct 19
2021
|
Mark A Schlossberg SVP - Legal & General Counsel |
SELL
Open market or private sale
|
Direct |
19,979
-28.21%
|
$699,265
$35.74 P/Share
|
|
Oct 19
2021
|
Mark A Schlossberg SVP - Legal & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
19,979
+22.0%
|
$139,853
$7.03 P/Share
|
|
Oct 14
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$185,000
$37.74 P/Share
|
|
Oct 14
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.0 P/Share
|
|
Oct 14
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.31%
|
$74,000
$37.73 P/Share
|
|
Oct 01
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+2.54%
|
$5,508
$36.74 P/Share
|
|
Oct 01
2021
|
L Patrick Gage Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+1.73%
|
$18,360
$36.74 P/Share
|
|
Oct 01
2021
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+2.26%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+2.54%
|
$5,508
$36.74 P/Share
|
|
Oct 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
7,569
-5.23%
|
$264,915
$35.14 P/Share
|